Edward A. Copelan
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation 81
- Acute Myeloid Leukemia Research 69
- Multiple Myeloma Research and Treatments 22
- Chronic Myeloid Leukemia Treatments 20
- Transplantation top 1%
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 23
- Chronic Lymphocytic Leukemia Research 18
- Oncology top 2%
- Immunology top 2%
-
- Acute Lymphoblastic Leukemia research 49
-
- Lymphoma Diagnosis and Treatment 18
- Co-authors
- Matt KalaycioBrian J. BolwellHillard M. LazarusRonald SobecksBelinda R. AvalosLisa RybickiMikkael A. SekeresRobert M. Dean
- Cited by
- HematologyTransplantationGenetics
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (8 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Edward A. Copelan
177 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Hematology 3.9k
- Transplantation 263
- Genetics 933
- Oncology 1.4k
- Immunology 1.0k
Countries citing papers authored by Edward A. Copelan
This map shows the geographic impact of Edward A. Copelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward A. Copelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward A. Copelan more than expected).
Fields of papers citing papers by Edward A. Copelan
This network shows the impact of papers produced by Edward A. Copelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward A. Copelan. The network helps show where Edward A. Copelan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward A. Copelan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 43 | |
| 7 | 2018 | 9 | |
| 8 | 2017 | 0 | |
| 9 | 2017 | 6 | |
| 10 | Recent advances in hematopoietic cell transplantation in myelodysplastic syndrome. | 2017 | 1 |
| 11 | 2017 | 2 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2015 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2008 | 146 | |
| 19 | 2008 | 36 | |
| 20 | 2003 | 9 |
About Edward A. Copelan
Edward A. Copelan is a scholar working on Hematology, Genetics and Transplantation, having authored 194 papers that have together received 5.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (81 papers), Acute Myeloid Leukemia Research (69 papers), Acute Lymphoblastic Leukemia research (49 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Multiple Myeloma Research and Treatments (22 papers), Chronic Myeloid Leukemia Treatments (20 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Lymphoma Diagnosis and Treatment (18 papers). The work is most often cited by research in Hematology (3.9k citations), Transplantation (263 citations) and Genetics (933 citations). Edward A. Copelan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Matt Kalaycio, Brian J. Bolwell, Hillard M. Lazarus, Ronald Sobecks, Belinda R. Avalos, Lisa Rybicki, Mikkael A. Sekeres, Robert M. Dean, Brad Pohlman and Anjali S. Advani. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.